Cargando…

Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus

Respiratory syncytial virus (RSV) is the most common cause of respiratory tract infections in both children and elderly people. In this study we evaluated the short- and long-term protective efficacy of a single intranasal (IN) immunization with a RSV vaccine formulation consisting of a codon-optimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, R., Latimer, L., Gerdts, V., Potter, A., van Drunen Littel-van den Hurk, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718833/ https://www.ncbi.nlm.nih.gov/pubmed/28825870 http://dx.doi.org/10.1080/21645515.2017.1349584

Ejemplares similares

Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice
por: Martinez, Elisa C., et al.
Publicado: (2016)

Vaccine Potentiation by Combination Adjuvants
por: Levast, Benoît, et al.
Publicado: (2014)

Innate and Adaptive Immune Response to Pneumonia Virus of Mice in a Resistant and a Susceptible Mouse Strain
por: Watkiss, Ellen R. T., et al.
Publicado: (2013)

Effect of tunicamycin and monensin on biosynthesis, transport, and maturation of bovine herpesvirus type-1 glycoproteins
por: Van Drunen Littel-Van Den Hurk, Sylvia, et al.
Publicado: (1985)

Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV
por: Hughes, G., et al.
Publicado: (1988)

VP8, the Major Tegument Protein of Bovine Herpesvirus-1, Is Partially Packaged during Early Tegument Formation in a VP22-Dependent Manner
por: Sucharita, Soumya, et al.
Publicado: (2021)

Bovine Herpesvirus-1 Glycoprotein M Mediates the Translocation to the Golgi Apparatus and Packaging of VP8
por: Sucharita, Soumya, et al.
Publicado: (2022)

Comprehensive Analysis of the Tegument Proteins Involved in Capsid Transport and Virion Morphogenesis of Alpha, Beta and Gamma Herpesviruses
por: Sucharita, Soumya, et al.
Publicado: (2023)

Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinology
por: Alves Dummer, Luana, et al.
Publicado: (2014)

Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge
por: Patel, Girishchandra B., et al.
Publicado: (2010)

Structural, functional, and immunological characterization of bovine herpesvirus-1 glycoprotein gl expressed by recombinant baculovirus()
por: Van Drunen Littel-van den Hurk, S., et al.
Publicado: (1992)

Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice
por: Fu, Yuan-Hui, et al.
Publicado: (2013)

Intranasal immunization with W(80)5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model
por: Passmore, Crystal, et al.
Publicado: (2014)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
por: Falloon, Judith, et al.
Publicado: (2017)

The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
por: Huang, Lei, et al.
Publicado: (2022)

An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
por: Cherukuri, Anu, et al.
Publicado: (2012)

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
por: Sastry, Mallika, et al.
Publicado: (2017)

Mucosal Immune Responses to Respiratory Syncytial Virus
por: Barnes, Megan V. C., et al.
Publicado: (2022)

Pathogenesis of Respiratory Syncytial Virus Infection in BALB/c Mice Differs Between Intratracheal and Intranasal Inoculation
por: van Erp, Elisabeth A., et al.
Publicado: (2019)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017)

Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge
por: Zuo, Zonghui, et al.
Publicado: (2021)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein
por: Cullen, Lori McGinnes, et al.
Publicado: (2015)

Innate immune recognition of respiratory syncytial virus infection
por: Kim, Tae Hoon, et al.
Publicado: (2014)

Respiratory syncytial virus: The virus, the disease and the immune response
por: Ogra, Pearay L.
Publicado: (2004)

Respiratory syncytial virus: paying the immunity debt with interest
por: Hatter, Lee, et al.
Publicado: (2021)

Innate Immune Evasion by Human Respiratory Syncytial Virus
por: Ouyang, Yan, et al.
Publicado: (2022)

The efficacy of intranasal interferonα-2a in respiratory syncytial virus infection in volunteers
por: Higgins, P.G., et al.
Publicado: (1990)

CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
por: van Haren, Simon D., et al.
Publicado: (2022)

Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines
por: Gasper, David J., et al.
Publicado: (2016)

The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017)

A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination
por: Sato-Kaneko, Fumi, et al.
Publicado: (2022)

Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses
por: Kawai, Atsushi, et al.
Publicado: (2023)

Protection against Respiratory Syncytial Virus Infection by DNA Immunization
por: Li, Xiaomao, et al.
Publicado: (1998)

Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses
por: Lotz, Matthew T., et al.
Publicado: (2012)

Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses
por: Shafique, Muhammad, et al.
Publicado: (2013)

Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant
por: Dwivedi, Varun, et al.
Publicado: (2011)

Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
por: Kim, Ki-Hye, et al.
Publicado: (2015)

Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice
por: Zheng, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06kaqha72j9u2vae9doki2bf67